Literature DB >> 16989996

Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden.

L H Christensen1, G Engholm, R Cortes, J Ceberg, U Tange, M Andersson, A Bladström, H T Mouridsen, T Möller, Hans Storm.   

Abstract

The 5-year relative survival from breast cancer in Denmark is 10 percentage points lower than in Sweden. This difference has been demonstrated previously as being caused partly by more involved lymph nodes and larger tumours in Denmark. Sweden has had nationwide mammography-screening coverage since 1991, whereas this is still in its infancy in Denmark. In the search for an explanation for the remaining survival difference, patient delay was a likely candidate. This study compared patient delay and mammography-detection between two national regions. Data on patient delay and mammography were obtained from hospital records from 1989 and 1994, and analysed using Cox proportional hazard analysis of death within the first 5 years, with the factors age, country, delay/mammography detection and established patho-anatomic variables. A comparison of patient delay and mammography detection in 1989 and 1994 showed more mammography-detected tumours in south Sweden and more women with long delay in east Denmark. Mammography detection, but not long patient delay, had a significant effect on the death hazard when adjusting for patho-anatomic risk factors. The hazard ratio was not eliminated in 1989, but in 1994, the hazard ratio between east Denmark and south Sweden was reduced from 1.3 to 1.1. In conclusion, patient delay did not appear to have any effect on 5-year survival when adjusting for patho-anatomic factors, but tumour detection by mammography affected survival favourably and partly explained the survival difference between east Denmark and south Sweden.

Entities:  

Mesh:

Year:  2006        PMID: 16989996     DOI: 10.1016/j.ejca.2006.03.036

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study.

Authors:  Ashley Davidson; Stephen Chia; Robert Olson; Alan Nichol; Caroline Speers; Andy J Coldman; Chris Bajdik; Ryan Woods; Scott Tyldesley
Journal:  CMAJ Open       Date:  2013-11-07

2.  Radiologic findings of screen-detected cancers in an organized population-based screening mammography program in Turkey.

Authors:  Arda Kayhan; Erkin Arıbal; Cennet Şahin; Ömür Can Taşçı; Sibel Özkan Gürdal; Enis Öztürk; Hayat Halide Hatipoğlu; Nilüfer Özaydın; Neslihan Cabioğlu; Beyza Özçınar; Vahit Özmen
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

3.  Impact of a National Cancer Prevention and Treatment Program on the Prevalence of Late-Stage Breast Cancer Diagnoses in Oklahoma.

Authors:  Amanda Janitz; Aaron M Wendelboe; Ann F Chou; Summer Frank; Angela Watkins; David Thompson; Janis Campbell
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

4.  Trends in breast-conserving surgery in Denmark, 1982-2002.

Authors:  Thomas P Ahern; Heidi Larsson; Jens Peter Garne; Deirdre P Cronin-Fenton; Henrik Toft Sørensen; Timothy L Lash
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

5.  Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Authors:  Claudia Allemani; Milena Sant; Hannah K Weir; Lisa C Richardson; Paolo Baili; Hans Storm; Sabine Siesling; Ana Torrella-Ramos; Adri C Voogd; Tiiu Aareleid; Eva Ardanaz; Franco Berrino; Magdalena Bielska-Lasota; Susan Bolick; Claudia Cirilli; Marc Colonna; Paolo Contiero; Rosemary Cress; Emanuele Crocetti; John P Fulton; Pascale Grosclaude; Timo Hakulinen; M Isabel Izarzugaza; Per Malmström; Karin Peignaux; Maja Primic-Žakelj; Jadwiga Rachtan; Chakameh Safaei Diba; Maria-José Sánchez; Maria J Schymura; Tiefu Shen; Adele Traina; Laufey Tryggvadottir; Rosario Tumino; Michel Velten; Marina Vercelli; Holly J Wolf; Anne-Sophie Woronoff; Xiaocheng Wu; Michel P Coleman
Journal:  Int J Cancer       Date:  2012-09-18       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.